Search research articles
Contact Us
Filters
Showing results (1-10 of 100) with videos related to
Page
of 10
Sort By:
Seminars in Thrombosis and Hemostasis
|
February 9, 2012
The oral thrombin inhibitor dabigatran: strengths and weaknesses
Sam Schulman, Ammar Majeed
Drug Safety
|
May 19, 2011
A benefit-risk assessment of dabigatran in the prevention of venous thromboembolism in orthopaedic surgery
Sam Schulman, Ammar Majeed
Best Practice & Research. Clinical Haematology
|
August 20, 2013
Bleeding and antidotes in new oral anticoagulants
Ammar Majeed, Sam Schulman
Expert Opinion on Therapeutic Targets
|
November 3, 2021
A short report on NGM282/aldafermin for the treatment of nonalcoholic steatohepatitis (NASH)
Stuart K Roberts, Ammar Majeed
Thrombosis Research
|
April 13, 2016
Management of bleeding complications in patients with cancer on DOACs
Sam Schulman, Jeffrey Shrum, Ammar Majeed
Gastroenterology
|
December 14, 2018
RE: No Association Between Screening for Hepatocellular Carcinoma and Reduced Cancer-Related Mortality in Patients With Cirrhosis
Ammar Majeed, Stuart K Roberts, William Kemp
Clinics in Liver Disease
|
October 1, 2021
Controversies in the Management of Hepatitis B: Hepatocellular Carcinoma
Stuart K Roberts, Ammar Majeed, William Kemp
BMJ Open
|
October 2, 2020
ABO blood group and the risk of aortic disease: a nationwide cohort study
Igor Zindovic, Gustaf Edgren, Shahab Nozohoor, et al.
Internal Medicine Journal
|
July 26, 2018
Long-term outcomes of primary sclerosing cholangitis: an Australian non-transplant tertiary hospital perspective
Elliot Freeman, Ammar Majeed, William Kemp, et al.
Seminars in Thrombosis and Hemostasis
|
September 15, 2020
Viscoelastic Tests as Point-of-Care Tests in the Assessment and Management of Bleeding and Thrombosis in Liver Disease
Natasha Janko, Ammar Majeed, William Kemp, et al.
Page
of 10
Search research articles
Search
Showing results (1-10 of 100) with videos related to
Sort By:
Page
of 10
Seminars in Thrombosis and Hemostasis
|
February 9, 2012
The oral thrombin inhibitor dabigatran: strengths and weaknesses
Sam Schulman, Ammar Majeed
Drug Safety
|
May 19, 2011
A benefit-risk assessment of dabigatran in the prevention of venous thromboembolism in orthopaedic surgery
Sam Schulman, Ammar Majeed
Best Practice & Research. Clinical Haematology
|
August 20, 2013
Bleeding and antidotes in new oral anticoagulants
Ammar Majeed, Sam Schulman
Expert Opinion on Therapeutic Targets
|
November 3, 2021
A short report on NGM282/aldafermin for the treatment of nonalcoholic steatohepatitis (NASH)
Stuart K Roberts, Ammar Majeed
Thrombosis Research
|
April 13, 2016
Management of bleeding complications in patients with cancer on DOACs
Sam Schulman, Jeffrey Shrum, Ammar Majeed
Gastroenterology
|
December 14, 2018
RE: No Association Between Screening for Hepatocellular Carcinoma and Reduced Cancer-Related Mortality in Patients With Cirrhosis
Ammar Majeed, Stuart K Roberts, William Kemp
Clinics in Liver Disease
|
October 1, 2021
Controversies in the Management of Hepatitis B: Hepatocellular Carcinoma
Stuart K Roberts, Ammar Majeed, William Kemp
BMJ Open
|
October 2, 2020
ABO blood group and the risk of aortic disease: a nationwide cohort study
Igor Zindovic, Gustaf Edgren, Shahab Nozohoor, et al.
Internal Medicine Journal
|
July 26, 2018
Long-term outcomes of primary sclerosing cholangitis: an Australian non-transplant tertiary hospital perspective
Elliot Freeman, Ammar Majeed, William Kemp, et al.
Seminars in Thrombosis and Hemostasis
|
September 15, 2020
Viscoelastic Tests as Point-of-Care Tests in the Assessment and Management of Bleeding and Thrombosis in Liver Disease
Natasha Janko, Ammar Majeed, William Kemp, et al.
Page
of 10